nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—BCHE—Triamcinolone—ankylosing spondylitis	0.349	0.518	CbGbCtD
Rivastigmine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.07	0.104	CbGbCtD
Rivastigmine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.053	0.0788	CbGbCtD
Rivastigmine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0455	0.0676	CbGbCtD
Rivastigmine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0449	0.0667	CbGbCtD
Rivastigmine—CYP3A4—Prednisone—ankylosing spondylitis	0.0424	0.063	CbGbCtD
Rivastigmine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0416	0.0619	CbGbCtD
Rivastigmine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0265	0.0393	CbGbCtD
Rivastigmine—Infection—Methylprednisolone—ankylosing spondylitis	0.000263	0.000803	CcSEcCtD
Rivastigmine—Haematuria—Methotrexate—ankylosing spondylitis	0.000262	0.0008	CcSEcCtD
Rivastigmine—Shock—Triamcinolone—ankylosing spondylitis	0.000261	0.000797	CcSEcCtD
Rivastigmine—Insomnia—Prednisolone—ankylosing spondylitis	0.000261	0.000797	CcSEcCtD
Rivastigmine—Alopecia—Prednisone—ankylosing spondylitis	0.00026	0.000796	CcSEcCtD
Rivastigmine—Shock—Methylprednisolone—ankylosing spondylitis	0.00026	0.000795	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000259	0.000793	CcSEcCtD
Rivastigmine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000259	0.000792	CcSEcCtD
Rivastigmine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000259	0.000791	CcSEcCtD
Rivastigmine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000259	0.000791	CcSEcCtD
Rivastigmine—Epistaxis—Methotrexate—ankylosing spondylitis	0.000259	0.000791	CcSEcCtD
Rivastigmine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000259	0.000791	CcSEcCtD
Rivastigmine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000259	0.00079	CcSEcCtD
Rivastigmine—Mental disorder—Prednisone—ankylosing spondylitis	0.000258	0.000789	CcSEcCtD
Rivastigmine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000258	0.000789	CcSEcCtD
Rivastigmine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000257	0.000785	CcSEcCtD
Rivastigmine—Erythema—Prednisone—ankylosing spondylitis	0.000257	0.000784	CcSEcCtD
Rivastigmine—Malnutrition—Prednisone—ankylosing spondylitis	0.000257	0.000784	CcSEcCtD
Rivastigmine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000256	0.000783	CcSEcCtD
Rivastigmine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000256	0.000781	CcSEcCtD
Rivastigmine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000255	0.00078	CcSEcCtD
Rivastigmine—Convulsion—Betamethasone—ankylosing spondylitis	0.000255	0.00078	CcSEcCtD
Rivastigmine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000254	0.000777	CcSEcCtD
Rivastigmine—Hypertension—Betamethasone—ankylosing spondylitis	0.000254	0.000777	CcSEcCtD
Rivastigmine—Myalgia—Betamethasone—ankylosing spondylitis	0.000251	0.000767	CcSEcCtD
Rivastigmine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000251	0.000767	CcSEcCtD
Rivastigmine—Anxiety—Dexamethasone—ankylosing spondylitis	0.00025	0.000764	CcSEcCtD
Rivastigmine—Anxiety—Betamethasone—ankylosing spondylitis	0.00025	0.000764	CcSEcCtD
Rivastigmine—Discomfort—Betamethasone—ankylosing spondylitis	0.000248	0.000757	CcSEcCtD
Rivastigmine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000248	0.000757	CcSEcCtD
Rivastigmine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000248	0.000757	CcSEcCtD
Rivastigmine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000247	0.000755	CcSEcCtD
Rivastigmine—Pain—Prednisolone—ankylosing spondylitis	0.000246	0.000753	CcSEcCtD
Rivastigmine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000246	0.000753	CcSEcCtD
Rivastigmine—Hepatitis—Methotrexate—ankylosing spondylitis	0.000246	0.000753	CcSEcCtD
Rivastigmine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000244	0.000747	CcSEcCtD
Rivastigmine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000243	0.000743	CcSEcCtD
Rivastigmine—Vision blurred—Prednisone—ankylosing spondylitis	0.000242	0.000739	CcSEcCtD
Rivastigmine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000241	0.000738	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000241	0.000738	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000241	0.000736	CcSEcCtD
Rivastigmine—Oedema—Dexamethasone—ankylosing spondylitis	0.00024	0.000735	CcSEcCtD
Rivastigmine—Oedema—Betamethasone—ankylosing spondylitis	0.00024	0.000735	CcSEcCtD
Rivastigmine—Insomnia—Triamcinolone—ankylosing spondylitis	0.00024	0.000732	CcSEcCtD
Rivastigmine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000239	0.000731	CcSEcCtD
Rivastigmine—Infection—Betamethasone—ankylosing spondylitis	0.000239	0.00073	CcSEcCtD
Rivastigmine—Infection—Dexamethasone—ankylosing spondylitis	0.000239	0.00073	CcSEcCtD
Rivastigmine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000238	0.000728	CcSEcCtD
Rivastigmine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000238	0.000727	CcSEcCtD
Rivastigmine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000237	0.000726	CcSEcCtD
Rivastigmine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000237	0.000726	CcSEcCtD
Rivastigmine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000237	0.000725	CcSEcCtD
Rivastigmine—Anaemia—Prednisone—ankylosing spondylitis	0.000237	0.000725	CcSEcCtD
Rivastigmine—Shock—Betamethasone—ankylosing spondylitis	0.000237	0.000723	CcSEcCtD
Rivastigmine—Shock—Dexamethasone—ankylosing spondylitis	0.000237	0.000723	CcSEcCtD
Rivastigmine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000236	0.000722	CcSEcCtD
Rivastigmine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000236	0.000721	CcSEcCtD
Rivastigmine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000236	0.000721	CcSEcCtD
Rivastigmine—Agitation—Prednisone—ankylosing spondylitis	0.000236	0.000721	CcSEcCtD
Rivastigmine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000235	0.000719	CcSEcCtD
Rivastigmine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000235	0.000719	CcSEcCtD
Rivastigmine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000235	0.000717	CcSEcCtD
Rivastigmine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000235	0.000717	CcSEcCtD
Rivastigmine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000233	0.000713	CcSEcCtD
Rivastigmine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000233	0.000712	CcSEcCtD
Rivastigmine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000233	0.000711	CcSEcCtD
Rivastigmine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000232	0.00071	CcSEcCtD
Rivastigmine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000232	0.00071	CcSEcCtD
Rivastigmine—Malaise—Prednisone—ankylosing spondylitis	0.000231	0.000707	CcSEcCtD
Rivastigmine—Vertigo—Prednisone—ankylosing spondylitis	0.000231	0.000704	CcSEcCtD
Rivastigmine—Eye disorder—Methotrexate—ankylosing spondylitis	0.00023	0.000704	CcSEcCtD
Rivastigmine—Syncope—Prednisone—ankylosing spondylitis	0.00023	0.000703	CcSEcCtD
Rivastigmine—Tinnitus—Methotrexate—ankylosing spondylitis	0.00023	0.000702	CcSEcCtD
Rivastigmine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000229	0.0007	CcSEcCtD
Rivastigmine—Anorexia—Betamethasone—ankylosing spondylitis	0.000229	0.0007	CcSEcCtD
Rivastigmine—Urticaria—Prednisolone—ankylosing spondylitis	0.000229	0.0007	CcSEcCtD
Rivastigmine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000229	0.000699	CcSEcCtD
Rivastigmine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000228	0.000698	CcSEcCtD
Rivastigmine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000228	0.000697	CcSEcCtD
Rivastigmine—Pain—Triamcinolone—ankylosing spondylitis	0.000227	0.000693	CcSEcCtD
Rivastigmine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000225	0.000689	CcSEcCtD
Rivastigmine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000225	0.000687	CcSEcCtD
Rivastigmine—Hypotension—Betamethasone—ankylosing spondylitis	0.000225	0.000687	CcSEcCtD
Rivastigmine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000223	0.000683	CcSEcCtD
Rivastigmine—Convulsion—Prednisone—ankylosing spondylitis	0.000222	0.000679	CcSEcCtD
Rivastigmine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000222	0.000678	CcSEcCtD
Rivastigmine—Hypertension—Prednisone—ankylosing spondylitis	0.000222	0.000677	CcSEcCtD
Rivastigmine—Chills—Methotrexate—ankylosing spondylitis	0.000221	0.000675	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000219	0.000669	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000219	0.000669	CcSEcCtD
Rivastigmine—Myalgia—Prednisone—ankylosing spondylitis	0.000218	0.000668	CcSEcCtD
Rivastigmine—Arthralgia—Prednisone—ankylosing spondylitis	0.000218	0.000668	CcSEcCtD
Rivastigmine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000218	0.000667	CcSEcCtD
Rivastigmine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000218	0.000666	CcSEcCtD
Rivastigmine—Anxiety—Prednisone—ankylosing spondylitis	0.000218	0.000665	CcSEcCtD
Rivastigmine—Alopecia—Methotrexate—ankylosing spondylitis	0.000218	0.000665	CcSEcCtD
Rivastigmine—Insomnia—Betamethasone—ankylosing spondylitis	0.000217	0.000665	CcSEcCtD
Rivastigmine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000217	0.000665	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000217	0.000663	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000216	0.000661	CcSEcCtD
Rivastigmine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000216	0.00066	CcSEcCtD
Rivastigmine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000216	0.00066	CcSEcCtD
Rivastigmine—Discomfort—Prednisone—ankylosing spondylitis	0.000216	0.00066	CcSEcCtD
Rivastigmine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000216	0.00066	CcSEcCtD
Rivastigmine—Erythema—Methotrexate—ankylosing spondylitis	0.000214	0.000655	CcSEcCtD
Rivastigmine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000214	0.000655	CcSEcCtD
Rivastigmine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000212	0.000649	CcSEcCtD
Rivastigmine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000212	0.000647	CcSEcCtD
Rivastigmine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000212	0.000647	CcSEcCtD
Rivastigmine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000211	0.000643	CcSEcCtD
Rivastigmine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00021	0.000642	CcSEcCtD
Rivastigmine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00021	0.000642	CcSEcCtD
Rivastigmine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000209	0.00064	CcSEcCtD
Rivastigmine—Oedema—Prednisone—ankylosing spondylitis	0.000209	0.00064	CcSEcCtD
Rivastigmine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000209	0.000639	CcSEcCtD
Rivastigmine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000209	0.000639	CcSEcCtD
Rivastigmine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000209	0.000639	CcSEcCtD
Rivastigmine—Infection—Prednisone—ankylosing spondylitis	0.000208	0.000636	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000208	0.000634	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000208	0.000634	CcSEcCtD
Rivastigmine—Back pain—Methotrexate—ankylosing spondylitis	0.000207	0.000634	CcSEcCtD
Rivastigmine—Fatigue—Betamethasone—ankylosing spondylitis	0.000207	0.000634	CcSEcCtD
Rivastigmine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000207	0.000634	CcSEcCtD
Rivastigmine—Shock—Prednisone—ankylosing spondylitis	0.000206	0.00063	CcSEcCtD
Rivastigmine—Pain—Betamethasone—ankylosing spondylitis	0.000206	0.000628	CcSEcCtD
Rivastigmine—Pain—Dexamethasone—ankylosing spondylitis	0.000206	0.000628	CcSEcCtD
Rivastigmine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000205	0.000628	CcSEcCtD
Rivastigmine—Tachycardia—Prednisone—ankylosing spondylitis	0.000204	0.000625	CcSEcCtD
Rivastigmine—Skin disorder—Prednisone—ankylosing spondylitis	0.000203	0.000622	CcSEcCtD
Rivastigmine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000202	0.000619	CcSEcCtD
Rivastigmine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000202	0.000618	CcSEcCtD
Rivastigmine—Anorexia—Prednisone—ankylosing spondylitis	0.0002	0.00061	CcSEcCtD
Rivastigmine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000199	0.000608	CcSEcCtD
Rivastigmine—Anaemia—Methotrexate—ankylosing spondylitis	0.000198	0.000606	CcSEcCtD
Rivastigmine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000198	0.000606	CcSEcCtD
Rivastigmine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000198	0.000606	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000197	0.000601	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000197	0.000601	CcSEcCtD
Rivastigmine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000195	0.000597	CcSEcCtD
Rivastigmine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000195	0.000595	CcSEcCtD
Rivastigmine—Malaise—Methotrexate—ankylosing spondylitis	0.000193	0.000591	CcSEcCtD
Rivastigmine—Vertigo—Methotrexate—ankylosing spondylitis	0.000193	0.000589	CcSEcCtD
Rivastigmine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000191	0.000584	CcSEcCtD
Rivastigmine—Urticaria—Betamethasone—ankylosing spondylitis	0.000191	0.000584	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000191	0.000583	CcSEcCtD
Rivastigmine—Dizziness—Prednisolone—ankylosing spondylitis	0.000191	0.000582	CcSEcCtD
Rivastigmine—Asthenia—Triamcinolone—ankylosing spondylitis	0.00019	0.000581	CcSEcCtD
Rivastigmine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00019	0.000581	CcSEcCtD
Rivastigmine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00019	0.000581	CcSEcCtD
Rivastigmine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00019	0.000581	CcSEcCtD
Rivastigmine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00019	0.000581	CcSEcCtD
Rivastigmine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00019	0.00058	CcSEcCtD
Rivastigmine—Insomnia—Prednisone—ankylosing spondylitis	0.000189	0.000579	CcSEcCtD
Rivastigmine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000188	0.000575	CcSEcCtD
Rivastigmine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000187	0.000573	CcSEcCtD
Rivastigmine—Cough—Methotrexate—ankylosing spondylitis	0.000187	0.000572	CcSEcCtD
Rivastigmine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000187	0.000572	CcSEcCtD
Rivastigmine—Convulsion—Methotrexate—ankylosing spondylitis	0.000186	0.000568	CcSEcCtD
Rivastigmine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000184	0.000563	CcSEcCtD
Rivastigmine—Myalgia—Methotrexate—ankylosing spondylitis	0.000183	0.000558	CcSEcCtD
Rivastigmine—Chest pain—Methotrexate—ankylosing spondylitis	0.000183	0.000558	CcSEcCtD
Rivastigmine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000183	0.000558	CcSEcCtD
Rivastigmine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000182	0.000556	CcSEcCtD
Rivastigmine—Rash—Prednisolone—ankylosing spondylitis	0.000182	0.000555	CcSEcCtD
Rivastigmine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000182	0.000555	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000181	0.000554	CcSEcCtD
Rivastigmine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000181	0.000553	CcSEcCtD
Rivastigmine—Fatigue—Prednisone—ankylosing spondylitis	0.000181	0.000552	CcSEcCtD
Rivastigmine—Headache—Prednisolone—ankylosing spondylitis	0.000181	0.000552	CcSEcCtD
Rivastigmine—Discomfort—Methotrexate—ankylosing spondylitis	0.00018	0.000551	CcSEcCtD
Rivastigmine—Constipation—Prednisone—ankylosing spondylitis	0.000179	0.000547	CcSEcCtD
Rivastigmine—Confusional state—Methotrexate—ankylosing spondylitis	0.000176	0.000539	CcSEcCtD
Rivastigmine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000175	0.000536	CcSEcCtD
Rivastigmine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000175	0.000534	CcSEcCtD
Rivastigmine—Infection—Methotrexate—ankylosing spondylitis	0.000174	0.000531	CcSEcCtD
Rivastigmine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000173	0.000527	CcSEcCtD
Rivastigmine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000173	0.000527	CcSEcCtD
Rivastigmine—Asthenia—Betamethasone—ankylosing spondylitis	0.000173	0.000527	CcSEcCtD
Rivastigmine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000172	0.000524	CcSEcCtD
Rivastigmine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000171	0.000524	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000171	0.000523	CcSEcCtD
Rivastigmine—Nausea—Prednisolone—ankylosing spondylitis	0.000171	0.000523	CcSEcCtD
Rivastigmine—Pruritus—Betamethasone—ankylosing spondylitis	0.00017	0.00052	CcSEcCtD
Rivastigmine—Pruritus—Dexamethasone—ankylosing spondylitis	0.00017	0.00052	CcSEcCtD
Rivastigmine—Skin disorder—Methotrexate—ankylosing spondylitis	0.00017	0.000519	CcSEcCtD
Rivastigmine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000169	0.000517	CcSEcCtD
Rivastigmine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000168	0.000515	CcSEcCtD
Rivastigmine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000168	0.000514	CcSEcCtD
Rivastigmine—Rash—Triamcinolone—ankylosing spondylitis	0.000167	0.000511	CcSEcCtD
Rivastigmine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000167	0.00051	CcSEcCtD
Rivastigmine—Anorexia—Methotrexate—ankylosing spondylitis	0.000167	0.00051	CcSEcCtD
Rivastigmine—Rash—Methylprednisolone—ankylosing spondylitis	0.000167	0.00051	CcSEcCtD
Rivastigmine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000167	0.000509	CcSEcCtD
Rivastigmine—Urticaria—Prednisone—ankylosing spondylitis	0.000166	0.000508	CcSEcCtD
Rivastigmine—Headache—Triamcinolone—ankylosing spondylitis	0.000166	0.000507	CcSEcCtD
Rivastigmine—Headache—Methylprednisolone—ankylosing spondylitis	0.000166	0.000506	CcSEcCtD
Rivastigmine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000166	0.000506	CcSEcCtD
Rivastigmine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000166	0.000506	CcSEcCtD
Rivastigmine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000165	0.000503	CcSEcCtD
Rivastigmine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000165	0.000503	CcSEcCtD
Rivastigmine—Hypotension—Methotrexate—ankylosing spondylitis	0.000164	0.0005	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000159	0.000487	CcSEcCtD
Rivastigmine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000159	0.000486	CcSEcCtD
Rivastigmine—Dizziness—Betamethasone—ankylosing spondylitis	0.000159	0.000486	CcSEcCtD
Rivastigmine—Insomnia—Methotrexate—ankylosing spondylitis	0.000158	0.000484	CcSEcCtD
Rivastigmine—Nausea—Triamcinolone—ankylosing spondylitis	0.000157	0.000481	CcSEcCtD
Rivastigmine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000157	0.00048	CcSEcCtD
Rivastigmine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000157	0.00048	CcSEcCtD
Rivastigmine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000156	0.000477	CcSEcCtD
Rivastigmine—Somnolence—Methotrexate—ankylosing spondylitis	0.000156	0.000475	CcSEcCtD
Rivastigmine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000154	0.000471	CcSEcCtD
Rivastigmine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000154	0.000471	CcSEcCtD
Rivastigmine—Vomiting—Betamethasone—ankylosing spondylitis	0.000153	0.000467	CcSEcCtD
Rivastigmine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000153	0.000467	CcSEcCtD
Rivastigmine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000152	0.000465	CcSEcCtD
Rivastigmine—Rash—Betamethasone—ankylosing spondylitis	0.000152	0.000463	CcSEcCtD
Rivastigmine—Rash—Dexamethasone—ankylosing spondylitis	0.000152	0.000463	CcSEcCtD
Rivastigmine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000151	0.000463	CcSEcCtD
Rivastigmine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000151	0.000463	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000151	0.000462	CcSEcCtD
Rivastigmine—Fatigue—Methotrexate—ankylosing spondylitis	0.000151	0.000461	CcSEcCtD
Rivastigmine—Headache—Dexamethasone—ankylosing spondylitis	0.000151	0.00046	CcSEcCtD
Rivastigmine—Headache—Betamethasone—ankylosing spondylitis	0.000151	0.00046	CcSEcCtD
Rivastigmine—Asthenia—Prednisone—ankylosing spondylitis	0.00015	0.000459	CcSEcCtD
Rivastigmine—Pain—Methotrexate—ankylosing spondylitis	0.00015	0.000457	CcSEcCtD
Rivastigmine—Pruritus—Prednisone—ankylosing spondylitis	0.000148	0.000453	CcSEcCtD
Rivastigmine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000144	0.000441	CcSEcCtD
Rivastigmine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000143	0.000438	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000143	0.000437	CcSEcCtD
Rivastigmine—Nausea—Betamethasone—ankylosing spondylitis	0.000143	0.000436	CcSEcCtD
Rivastigmine—Nausea—Dexamethasone—ankylosing spondylitis	0.000143	0.000436	CcSEcCtD
Rivastigmine—Urticaria—Methotrexate—ankylosing spondylitis	0.000139	0.000425	CcSEcCtD
Rivastigmine—Dizziness—Prednisone—ankylosing spondylitis	0.000138	0.000423	CcSEcCtD
Rivastigmine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000138	0.000423	CcSEcCtD
Rivastigmine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000138	0.000423	CcSEcCtD
Rivastigmine—Vomiting—Prednisone—ankylosing spondylitis	0.000133	0.000407	CcSEcCtD
Rivastigmine—Rash—Prednisone—ankylosing spondylitis	0.000132	0.000403	CcSEcCtD
Rivastigmine—Dermatitis—Prednisone—ankylosing spondylitis	0.000132	0.000403	CcSEcCtD
Rivastigmine—Headache—Prednisone—ankylosing spondylitis	0.000131	0.000401	CcSEcCtD
Rivastigmine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000129	0.000394	CcSEcCtD
Rivastigmine—Asthenia—Methotrexate—ankylosing spondylitis	0.000126	0.000384	CcSEcCtD
Rivastigmine—Nausea—Prednisone—ankylosing spondylitis	0.000124	0.00038	CcSEcCtD
Rivastigmine—Pruritus—Methotrexate—ankylosing spondylitis	0.000124	0.000378	CcSEcCtD
Rivastigmine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00012	0.000366	CcSEcCtD
Rivastigmine—Dizziness—Methotrexate—ankylosing spondylitis	0.000116	0.000354	CcSEcCtD
Rivastigmine—Vomiting—Methotrexate—ankylosing spondylitis	0.000111	0.00034	CcSEcCtD
Rivastigmine—Rash—Methotrexate—ankylosing spondylitis	0.00011	0.000337	CcSEcCtD
Rivastigmine—Dermatitis—Methotrexate—ankylosing spondylitis	0.00011	0.000337	CcSEcCtD
Rivastigmine—Headache—Methotrexate—ankylosing spondylitis	0.00011	0.000335	CcSEcCtD
Rivastigmine—Nausea—Methotrexate—ankylosing spondylitis	0.000104	0.000318	CcSEcCtD
